This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 May;31(2):489-502.

doi: 10.1081/dmr-100101932.

Arylamine N-acetyltransferase activity in man

I Cascorbi¹, J Brockmöller, P M Mrozikiewicz, A Müller, I Roots

Affiliations

PMID: 10335449
DOI: 10.1081/dmr-100101932

Review

Arylamine N-acetyltransferase activity in man

I Cascorbi et al. Drug Metab Rev. 1999 May.

. 1999 May;31(2):489-502.

doi: 10.1081/dmr-100101932.

Authors

I Cascorbi¹, J Brockmöller, P M Mrozikiewicz, A Müller, I Roots

Affiliation

¹ Institute of Clinical Pharmacology, University Clinic Charité, Humboldt University Berlin, Germany. ingolf.cascorbi@charite.de

PMID: 10335449
DOI: 10.1081/dmr-100101932

No abstract available

PubMed Disclaimer

Similar articles

Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
Bruhn C, Brockmöller J, Cascorbi I, Roots I, Borchert HH. Bruhn C, et al. Biochem Pharmacol. 1999 Dec 1;58(11):1759-64. doi: 10.1016/s0006-2952(99)00269-5. Biochem Pharmacol. 1999. PMID: 10571250
Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
Roots I, Brockmöller J, Drakoulis N, Loddenkemper R. Roots I, et al. Clin Investig. 1992 Mar-Apr;70(3-4):307-19. doi: 10.1007/BF00184667. Clin Investig. 1992. PMID: 1355678
Polymorphism of arylamine-N-acetyltransferase 2 gene is associated with the risk of atopic dermatitis.
Makarova SI, Dodunova EM, Ivanova GG, Vavilin VA, Kaznacheeva LF, Lyakhovich VV. Makarova SI, et al. Bull Exp Biol Med. 2005 Jun;139(6):662-4. doi: 10.1007/s10517-005-0371-6. Bull Exp Biol Med. 2005. PMID: 16224574
[Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].
Kłodowska-Duda GA, Samelska JA, Opala GM. Kłodowska-Duda GA, et al. Wiad Lek. 2005;58(3-4):212-7. Wiad Lek. 2005. PMID: 16119167 Review. Polish.
Review of studies of selected metabolic polymorphisms and cancer.
d'Errico A, Malats N, Vineis P, Boffetta P. d'Errico A, et al. IARC Sci Publ. 1999;(148):323-93. IARC Sci Publ. 1999. PMID: 10493265 Review. No abstract available.

See all similar articles

Cited by

Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.
Salazar-González R, Gómez R, Romano-Moreno S, Medellín-Garibay S, Núñez-Ruíz A, Magaña-Aquino M, Milán-Segovia RC, Portales-Pérez DP. Salazar-González R, et al. Mol Biol Rep. 2014 Dec;41(12):7833-43. doi: 10.1007/s11033-014-3677-5. Epub 2014 Aug 28. Mol Biol Rep. 2014. PMID: 25163630
Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.
Littorin M, Hou S, Broberg K, Björk J, Fält S, Abdoulaye G, Kalemba M, Ryk C, Skerfving S. Littorin M, et al. Int Arch Occup Environ Health. 2008 Feb;81(4):429-41. doi: 10.1007/s00420-007-0232-x. Epub 2007 Aug 4. Int Arch Occup Environ Health. 2008. PMID: 17676332
The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype.
Ruiz JD, Martínez C, Anderson K, Gross M, Lang NP, García-Martín E, Agúndez JA. Ruiz JD, et al. PLoS One. 2012;7(9):e44629. doi: 10.1371/journal.pone.0044629. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970273 Free PMC article.
Introducing pharmacy students to pharmacogenomic analysis.
Krynetskiy E, Lee Calligaro I. Krynetskiy E, et al. Am J Pharm Educ. 2009 Jul 10;73(4):71. doi: 10.5688/aj730471. Am J Pharm Educ. 2009. PMID: 19657504 Free PMC article.
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
Skretkowicz K, Skretkowicz J, Gawrońska-Szklarz B, Górnik W, Rychlik-Sych M, Sysa-Jedrzejowska A. Skretkowicz K, et al. Eur J Clin Pharmacol. 2005 Jan;60(11):773-8. doi: 10.1007/s00228-004-0837-x. Epub 2004 Nov 24. Eur J Clin Pharmacol. 2005. PMID: 15565348

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon